University of Maryland School of Medicine Faculty Member Credited for Developing Unique Oncology Partnership with Johns Hopkins
Maryland Gov. Larry Hogan today recognized Sally B. Cheston, MD, an assistant professor of radiation oncology at the University of Maryland School of Medicine (UMSOM), for her efforts to bring the “latest state-of-the-art medicine” to Howard County as a leader of the Central Maryland Radiation Oncology Center (CMRO). The governor commended Dr. Cheston, a radiation oncologist with more than 20 years’ experience who specializes in treating breast cancer and lung cancer, for her professional achievements and significant contributions as a “critical part of the fabric of the community.”
State Health Secretary Robert Neall presented Dr. Cheston with a citation from Governor Hogan at CMRO, a community practice operated by the University of Maryland Medical Center (UMMC) and Johns Hopkins Medicine, located at Howard County General Hospital in Columbia, Md. Dr. Cheston was instrumental in forging the unique partnership between the two academic medical centers and serves as the practice’s medical director.
“Dr. Cheston is what every university medical school hopes to find, but is, in fact, quite rare. She is a dedicated community-based faculty practitioner who cares first and above all about her patients while serving as a leader and innovator in her practice setting and beyond,” says William F. Regine, MD, FACR, FACRO, the Isadore & Fannie Schneider Foxman Endowed Chair and professor of radiation oncology at UMSOM and chief of radiation oncology at the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC).
“The result has been wide recognition throughout the state and extraordinary confidence in her abilities, as reported by community physicians and their patients in Maryland. She deserves recognition for her selfless and longstanding service and accomplishments, which will doubtless continue well into the future.” Dr. Regine says.
About the University of Maryland School of Medicine
Commemorating its 210th Anniversary, the University of Maryland School of Medicine was chartered in 1807 as the first public medical school in the United States. It continues today as one of the fastest growing, top-tier biomedical research enterprises in the world -- with 43 academic departments, centers, institutes, and programs; and a faculty of more than 3,000 physicians, scientists, and allied health professionals, including members of the National Academy of Medicine and the National Academy of Sciences, and a distinguished recipient of the Albert E. Lasker Award in Medical Research. With an operating budget of more than $1 billion, the School of Medicine works closely in partnership with the University of Maryland Medical Center and Medical System to provide research-intensive, academic and clinically-based care for more than 1.2 million patients each year. The School has over 2,500 students, residents, and fellows, and nearly $450 million in extramural funding, with most of its academic departments highly ranked among all medical schools in the nation in research funding. As one of the seven professional schools that make up the University of Maryland Baltimore campus, the School of Medicine has a total workforce of nearly 7,000 individuals. The combined School and Medical System (“University of Maryland Medicine”) has an annual budget of nearly $6 billion and an economic impact in excess of $15 billion on the state and local community. The School of Medicine faculty, which ranks as the 8th-highest public medical school in research productivity, is an innovator in translational medicine, with 600 active patents and 24 start-up companies. The School works locally, nationally, and globally, with research and treatment facilities in 36 countries around the world. Visit medschool.umaryland.edu/